Qsam Biosciences Inc   (APGR)
Other Ticker:  


Qsam Biosciences Inc

APGR's Financial Statements and Analysis

Qsam Biosciences Inc increased III. Quarter net loss per share of $-0.75 compare to net loss per share of $-0.06 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.79 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.75 $  0 Mill
$-0.69     Unch.    

Qsam Biosciences Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.

Qsam Biosciences Inc is Expected to report next financial results on February 23, 2023.

More on APGR's Income Statement

Qsam Biosciences Inc 's in III. Quarter recorded net loss of $-1.272 million, an increase from net loss of $-1.054 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.283 million realized in previous quarter.

More on APGR's Growth

APGR's Cash flow In III. Quarter company's net cash flow was $0 million

Qsam Biosciences Inc does not pay out common stock dividend.

In trailing twelve-month period Qsam Biosciences Inc payed $ -1.30 cash per share, on a free-cash flow basis .